Squamous cell carcinoma is the
second most common type of skin cancer after basal cell carcinoma. The cancer
is characterized by uncontrolled growth of squamous cells that are found in the
middle and outer epidermal layers of the skin. Squamous cell carcinoma of the
skin is also referred as cutaneous cell carcinoma to differentiate it from the
other types of squamous cell carcinomas including squamous-cell carcinoma of
the lung, squamous cell thyroid carcinoma, esophageal squamous cell carcinoma,
and squamous-cell carcinoma of the vagina.
Read Report Overview - https://www.transparencymarketresearch.com/squamous-cell-carcinoma-treatment-market.html
Squamous cell carcinoma is
generally caused due to excessive exposure of skin to the harmful ultraviolet
rays of sun. However, a number of other factors are being related to elevated
risks of developing squamous cell carcinoma including old age, genetic inheritance,
Caucasian features including light skin color, red or blonde hair, blue, green
colored eyes, exposure to radiations, excessive use of tanning beds or UV
lamps, and HIV, HPV or AIDS infection.
Squamous cell carcinoma is a
relatively slow growing skin cancer compared to other skin malignancies;
however, if not detected at an early stage, the cancer can metastasize to other
organs of the body such as lungs, bones, and lymph nodes, and become hard to
treat. Squamous cell carcinoma can occur in any part of the body including the
mucosal linings of mouth, anus, and genitals. It generally begins with firm,
flat or raised, red nodules with a rough scaly skin. The patch can turn into a
sore, bleeding patch, or wart-like sore with disease progression.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71367
Global Squamous Cell Carcinoma
Treatment Market: Dynamics
Rise in Prevalence of
Non-melanoma Skin Cancer due to Environmental Factors Boosts Market
The global squamous cell
carcinoma treatment market is anticipated to grow at a steady pace during the
forecast period owing to a multitude of factors. Changes in environment
increase the incidence of numerous cutaneous malignancies including
non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma).
Depletion of the ozone layer of
atmosphere increases the penetration by harmful UV rays of the sun. Prolonged
exposure to the sun and factors such as fair complexion, exposure to chemical
carcinogens such as arsenic, and genetic factors elevate the risk of developing
squamous cell carcinoma. These environmental factors increase the rate of
prevalence of squamous cell carcinoma, especially among Caucasians, thereby
driving the global squamous cell carcinoma treatment market.
Surge in the geriatric
population, rise in initiatives to create disease awareness, and favorable
reimbursement scenario boost the demand for squamous cell carcinoma treatment
measures. However, high cost of the treatment and lack of awareness in
developing countries are anticipated to hamper the growth of the global
squamous cell carcinoma treatment market in the next few years.
Request for Analysis of COVID-19 Impact on Squamous Cell
Carcinoma Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71367
Global Squamous Cell Carcinoma
Treatment Market - Competitive Landscape
Major players operating in the
global squamous cell carcinoma treatment market include Regeneron
Pharmaceuticals, Inc., Sanofi, and Mylan N.V.
Regeneron Pharmaceuticals,
Inc.
Regeneron Pharmaceuticals, Inc.
is a U.S.-based biopharmaceutical company with medicines and pipeline designed
to treat eye diseases, allergic & inflammatory diseases, cancer,
cardiovascular & metabolic diseases, neuromuscular diseases, infectious
diseases, and rare diseases. The company’s recently approved Libtayo
(cemiplimab-rwlc) is indicated for the treatment of patients with metastatic
cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not
candidates for curative surgery or curative radiation.
Pre Book Squamous Cell Carcinoma Treatment Market Report
at https://www.transparencymarketresearch.com/checkout.php?rep_id=71367<ype=S
Sanofi
Sanofi is a multinational
pharmaceutical company headquartered in Paris, France. The company provides
services in more than 170 countries. It provides products across seven major
therapeutic areas: cardiovascular, central nervous system, diabetes, internal
medicine, oncology, thrombosis and vaccines. Sanofi’s subsidiary under the name
Sanofi Pasteur is one of the largest producers of life saving vaccines in the
world.
More Trending Reports by Transparency Market Research –
Non-invasive Prenatal Testing Market: https://www.prnewswire.com/news-releases/women-opting-for-late-motherhood-driving-demand-for-non-invasive-prenatal-testing-transparency-market-research-301005822.html
Viral Clearance Service Market: https://www.biospace.com/article/viral-clearance-service-market-recombinant-protein-to-account-for-a-major-share/
About Us
Transparency Market Research is a
global market intelligence company providing global business information reports
and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for several decision makers. Our
experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
